Symbol
| SUMO1
| contributors: mct/ - updated : 29-09-2018
|
HGNC name
| SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)
|
HGNC id
| 12502
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in autism with duplicated UBE3A | constitutional
|  
|  
|  
|  
|
haploinsufficiency leads to cleft lip and palate | constitutional
|  
|  
| --other
|  
|
alterations in SUMO1 substrate conjugation may occur and global posttranslational modifications by ubiquitin may play an important role in the mechanisms underlying Alzheimer disease | constitutional
|  
|  
| --over
|  
|
in isolated cardiomyocytes augmented contractility and accelerated Ca2+ decay | |
Susceptibility
|
to non-syndromic cleft lip with or without cleft palate (NSCLP) |
Variant & Polymorphism
SNP
| significant correlations between a 4-SNP SUMO1 haplotype and NSCLP |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cardiovascular | aquired | heart failure | |
targeting SUMO1 may provide a novel therapeutic strategy for the treatment of heart failure |
| | | |